White & Case LLP has advised Banca Farmafactoring on its initial public offering on the Milan Stock Exchange, in which approximately 30 percent of the company's ordinary shares were sold for a total amount of approximately €250 million.

Banca Farmafactoring specialises in the management, sale and non-recourse factoring of receivables owed to suppliers mainly by national healthcare service entities and other Italian public sector organisations.

Deutsche Bank AG, London Branch, Mediobanca - Banca di Credito Finanziario S.p.A. and Morgan Stanley & Co International plc acted as Joint Global Coordinators and Joint Bookrunners. BNP Paribas, Jefferies International Limited and UniCredit Bank AG, Milan Branch acted as Joint Bookrunners.

The White & Case team which advised on the transaction was led by partners Michael Immordino (London & Milan) and Ferigo Foscari (Milan), and included partners Marcin Studniarek (Warsaw) and Yoko Takagi (Madrid), local partner Juraj Fuska (Bratislava), counsel Bartosz Smardzewski (Warsaw) and associates Robert Becker, Martina Ferraro (both Milan), Monika Duzynska, Klaudia Malczewska (both Warsaw), Laura Gonzalez, Pedro Hendel (both Madrid) and Radoslav Palka (Bratislava), and lawyer Charles English (Milan).